共 50 条
- [3] Risedronate significantly reduces both vertebral and non-vertebral fractures in osteoporotic women. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S118 - S118
- [6] Risedronate reduces the risk of clinical vertebral fractures as early as 6 months and non-vertebral fractures as early as 12 months in women with postmenopausal osteoporosis. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S254 - S254